| Date | Title | Description |
| 25.02.2026 | Illumina launches TruPath Genome, setting a new standard in genomic insight | TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow
Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease
Broad Clinical Labs is among first to adopt product,... |
| 24.02.2026 | Cerebral Palsy Research Network Partners with GeneDx | The Cerebral Palsy Research Network
GeneDx, a leader in genetic testing, is the CP Research Network's partner for the first webinar in the series.
This young girl has cerebral palsy with an underlying genetic cause.
New six-part webinar ser... |
| 10.02.2026 | Florida law models what genetic disease testing could be | To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com
Florida state Rep. Adam Anderson championed the Sunshine Genetics Act, the first state-backed genetic disease screening program in the nation.
A... |
| 18.12.2025 | Friday could be a wild day of trading on Wall Street. Here’s why | More than $7.1 trillion in notional options exposure is set to expire this Friday, according to Goldman.
December options expirations are typically the biggest of the year, but this one eclipses all prior records.
Wall Street could be in fo... |
| 17.10.2025 | Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot | Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx
Constellation outperformed orthogonal methods in identifying select difficult-to-map variants
SAN DIEGO, Oct. 17, 2025 /PRNewswir... |
| 14.10.2025 | How a reluctant CEO conquered imposter syndrome to turn a biotech profitable | CNBC is now accepting nominations for the 2026 Changemakers list. Learn more and submit a nomination by Nov 21.
Katherine Stueland, CEO at genetics testing and genomics company GeneDx, turned a financially challenged firm profitable within ... |
| 07.10.2025 | Erosion of Trust: ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing | Dr. Mike Rossi, Vice President, Translational Science and Multi-Modal RWE Solutions at ConcertAI
The integrity of medical research is under siege. Last month, Med-Gemini’s “hallucination” of a part of the brain made headlines, but according... |
| 18.04.2025 | Featured.com Revives HARO: A New Dawn for Journalistic Integrity | In a world drowning in artificial intelligence and automated content, the acquisition of Help A Reporter Out (HARO) by Featured.com marks a pivotal moment for journalism. This deal, announced on April 16, 2025, is not just a business transa... |
| 18.04.2025 | GeneDx and Fabric Genomics: A New Era in Genomic Medicine | In the fast-paced world of healthcare, change is the only constant. The recent acquisition of Fabric Genomics by GeneDx marks a significant shift in the landscape of genomic medicine. This merger is not just a business deal; it’s a bold ste... |
| 16.04.2025 | Featured.com Acquires Help A Reporter Out | Featured.com, a Scottsdale, AZ-based platform that connects subject-matter experts with journalists, acquired Help A Reporter Out (HARO), a provider of a tool for journalists, from Cision.
The amount of the deal was not disclosed.
Thought t... |
| 16.04.2025 | GeneDx to Acquire Fabric Genomics | GeneDx (Nasdaq: WGS), a Stamford, CT-based company which specializes in delivering improved health outcomes through genomic insights, acquired Fabric Genomics, an Oakland, CA-based company which specializes in AI-powered genomic interpretat... |
| 16.04.2025 | GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale | Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to genomic information Accelerates the NICU, e... |
| 13.03.2025 | GeneDx Launches Multiscore: AI-Powered Tool for Genetic Analysis | What You Should Know:
– GeneDx, a leader in delivering improved health outcomes through genomic insights launches Multiscore, an advanced AI-powered decision support tool.
– Multiscore is designed to revolutionize genetic analysis by improv... |
| 24.02.2025 | Women Who Lead: The 2025 CNBC Changemakers and Their Impact | The landscape of business is changing. Women are stepping into the spotlight, breaking barriers, and redefining success. The 2025 CNBC Changemakers list showcases fifty remarkable women who are not just leaders but pioneers. They are shapin... |
| 24.02.2025 | From Google DeepMind to Skims and Reddit, Paris Hilton to Naomi Watts, Changemakers have a new model for success | Tune in all day for coverage of the 2025 CNBC Changemakers
The second annual CNBC Changemakers list of women transforming business and philanthropy recognizes leaders whose accomplishments span many fields and innovations.
Companies on the ... |
| 10.02.2025 | GeneDx Launches on Epic Aura, Expanding Access to Genomic Testing | What You Should Know:
– GeneDx, a leader in delivering improved health outcomes through genomic insights, today announced its launch on Epic Aura, a specialty diagnostics suite within Epic’s electronic health records (EHR).
– The integratio... |
| 20.11.2024 | GeneDx Launches Tool to Fuel Rare Disease Drug Discovery | What You Should Know:
– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
– The platform provides biopharmac... |
| 11.09.2024 | Oracle announces OCI advancements, unveils AI coding assistant | Oracle has announced new advancements to expedite application development and deployment on Oracle Cloud Infrastructure (OCI). Oracle Code Assist, an AI-powered coding assistant designed to enhance developer productivity, is now accessible ... |
| 22.08.2024 | Global Genes' Annual Week in RARE Event Heading to Kansas City | Global Genes
Global Genes is taking Week In RARE on the road to Kansas City, after having hosted this annual event in California for over 12 years. Moving the location annually will help make the event more accessible and equitable to the g... |
| 21.11.2023 | Why 1 Health System Is Embedding Genomics Into Primary Care | When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that.
Genomics is a key part of the health system’s approach to personalized care delivery, s... |
| 25.10.2023 | Health | Quick genetic test offers hope for sick, undiagnosed kids. But few insurers offer to pay | Phil Galewitz | (TNS) KFF Health News
Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction.
Two weeks later, she had another emergency surgery, and then developed men... |
| 08.07.2023 | PacBio and GeneDx Launches Research Collaboration | What You Should Know:
PacBio, a developer of high-quality, highly accurate sequencing solutions and GeneDx, a provider in delivering improved health outcomes through genomic and clinical insights, today announced a research collaboration wi... |
| 19.01.2022 | Inside crypto exchange FTX’s new venture fund | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
FTX wants to move fast.
Paid Content How to update cybersecurity in the face of potential attacks... |
| 19.01.2022 | Inside crypto exchange FTX’s new venture fund | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
FTX wants to move fast.
Paid Content Why today's marketers need strong collaboration tools From O... |
| 18.01.2022 | Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform | Business combination projected to deliver $350 million in pro forma 2022 revenue
$200 million private placement from leading growth and life sciences investors, including Pfizer, will fortify transaction and Sema4 balance sheet
Katherine St... |
| 18.01.2022 | Sema4 : to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform - Form 8-K | Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
Business combination projected to deliver $350 million in pro forma 2022 revenue
$200 million private placement from leading growth and l... |
| - | The DNA of better health care for rare diseases | Less than two decades into the genomic era in health care, our knowledge about the connections between DNA and human health continues to explode, from the genetic underpinnings of disease to how to use genetics to identify what therapy is b... |
